SPL submission deadline nears
This article was originally published in The Tan Sheet
Executive SummaryBeginning June 1, firms must electronically submit to FDA drug listings, establishment registrations for OTC products and labeler codes. The agency will accept paper submissions postmarked only through May 31. After that date, FDA will accept data for OTC and veterinary medicine products only submitted electronically in a Structured Product Labeling format (1"The Tan Sheet" Aug. 28, 2006, p. 12)
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.